Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy Article

cited authors

  • Tamaskar, Ila; Garcia, Jorge A.; Elson, Paul; Wood, Laura; Mekhail, Tarek; Dreicer, Robert; Rini, Brian I.; Bukowski, Ronald M.

authors

Publication Date

  • January 1, 2008

webpage

published in

category

keywords

  • angiogenesis inhibitors
  • carcinoma
  • renal cell
  • vascular endothelial growth factors

start page

  • 81

end page

  • 86

volume

  • 179

issue

  • 1